SLS (SELLAS Life Sciences Group) Short-term investments


SLS SELLAS Life Sciences Group Inc SLS
25 GF Score
Price $12.76
View Full Analysis

What is SELLAS Life Sciences Group Short-term investments?

Short-term investments only applies to insurance companies.

SLS
25GF Score
SELLAS Life Sciences Group Inc SLS
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SELLAS Life Sciences Group Business Description

Other Exchanges RXK3:Germany
Address 7 Times Square, Suite 2503, New York, NY, USA, 10036
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
25GF Score

Get the complete analysis for SLS

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.76
Price